T1	Participants 161 179	limited prognosis,
T2	Participants 528 567	patients in the palliative care setting
T3	Participants 680 959	Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease.
T4	Participants 1627 1639	381 patients